tiprankstipranks
Drug Free Solution Inc (DSOL)
OTHER OTC:DSOL
US Market

Drug Free Solution (DSOL) Ratios

9 Followers

Drug Free Solution Ratios

See a summary of DSOL’s cash flow.
Ratios
May 20May 19
Liquidity Ratios
Current Ratio
0.04
Quick Ratio
0.04
Cash Ratio
0.04
Solvency Ratio
-4.19
Operating Cash Flow Ratio
-1.15
Short-Term Operating Cash Flow Coverage
0.00
Net Current Asset Value
$ ―$ -320.80K
Leverage Ratios
Debt-to-Assets Ratio
0.00
Debt-to-Equity Ratio
0.00
Debt-to-Capital Ratio
0.00
Long-Term Debt-to-Capital Ratio
0.00
Financial Leverage Ratio
-0.19
Debt Service Coverage Ratio
0.00
Interest Coverage Ratio
0.00
Debt to Market Cap
0.00
Interest Debt Per Share
0.00
Net Debt to EBITDA
<0.01
Profitability Margins
Gross Profit Margin
100.00%
EBIT Margin
-174816.77%
EBITDA Margin
-173282.86%
Operating Profit Margin
-174817.39%
Pretax Profit Margin
-174816.77%
Net Profit Margin
-174816.77%
Continuous Operations Profit Margin
-174816.77%
Net Income Per EBT
100.00%
EBT Per EBIT
100.00%
Return on Assets (ROA)
-2680.17%
Return on Equity (ROE)
501.18%
Return on Capital Employed (ROCE)
501.18%
Return on Invested Capital (ROIC)
501.18%
Return on Tangible Assets
-11256.40%
Earnings Yield
-1.22%
Efficiency Ratios
Receivables Turnover
0.00
Payables Turnover
0.00
Inventory Turnover
0.00
Fixed Asset Turnover
0.00
Asset Turnover
0.02
Working Capital Turnover Ratio
>-0.01
Cash Conversion Cycle
0.00
Days of Sales Outstanding
0.00
Days of Inventory Outstanding
0.00
Days of Payables Outstanding
0.00
Operating Cycle
0.00
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01
Free Cash Flow Per Share
>-0.01
CapEx Per Share
<0.01
Free Cash Flow to Operating Cash Flow
1.10
Dividend Paid and CapEx Coverage Ratio
-10.40
Capital Expenditure Coverage Ratio
-10.40
Operating Cash Flow Coverage Ratio
0.00
Operating Cash Flow to Sales Ratio
-475.65
Free Cash Flow Yield
-0.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-82.05
Price-to-Sales (P/S) Ratio
143.43K
Price-to-Book (P/B) Ratio
-411.20
Price-to-Free Cash Flow (P/FCF) Ratio
-275.08
Price-to-Operating Cash Flow Ratio
-301.54
Price-to-Earnings Growth (PEG) Ratio
1.86
Price-to-Fair Value
-411.20
Enterprise Value Multiple
-82.76
Enterprise Value
115.45M
EV to EBITDA
-82.76
EV to Sales
143.41K
EV to Free Cash Flow
-275.05
EV to Operating Cash Flow
-301.51
Tangible Book Value Per Share
>-0.01
Shareholders’ Equity Per Share
>-0.01
Tax and Other Ratios
Effective Tax Rate
0.00
Revenue Per Share
<0.01
Net Income Per Share
>-0.01
Tax Burden
1.00
Interest Burden
1.00
Research & Development to Revenue
0.00
SG&A to Revenue
0.00
Stock-Based Compensation to Revenue
0.00
Income Quality
0.27
Currency in USD